{
    "nctId": "NCT02903524",
    "briefTitle": "Doxorubicin Hydrochloride Liposome Injection Combination With Cyclophosphamide vs Pirarubicin Combination With Cyclophosphamide in Patients With Locally Advanced Breast Cancer",
    "officialTitle": "The Efficacy and Safety of Doxorubicin Hydrochloride Liposome Injection Plus Cyclophosphamide Compared to Pirarubicin Plus Cyclophosphamide as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer \uff1aa Randomised Multicentre, Open-label Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE4",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 300,
    "primaryOutcomeMeasure": "pathological complete response",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients with age between 18 and 70 years.\n* Newly diagnosed breast cancer, stages IIb-IIIc.\n* KPS performance status\u226570.\n* Measurable disease according to RECIST version 1.1.\n* Normal cardiac function confirmed by baseline left ventricular ejection fraction (LVEF)\u226550%.\n* Adequate bone marrow reserve (WBC\u22654.0\u00d710(9)/L, neutrophils\u22652.0\u00d710(9)/L, platelets\u2265100\u00d710(9)/L,and hemoglobin\u226590g/L).\n* Adequate hepatic and renal function.\n* AST and ALT \u2264 2\u00d7institutional upper limit of normal\uff1balkaline phosphatase \u2264 2\u00d7institutional upper limit of normal\uff1bbilirubin \u2264 institutional upper limit of normal.\n* Serum creatinine\u226544 \u00b5mol/L and \u2264133 \u00b5mol/L.\n* Written informed consent are acquired.\n* Not in pregnancy or the pregnancy tests of females is negative.\n\nExclusion Criteria:\n\n* Severe heart failure (NYHA grade II or higher).\n* Active and uncontrolled severe infection.\n* Have accepted any other anti-tumor drug within 30 days before the first dose or\n* received radiation treatment.\n* Other situations that investigators consider as contra-indication for this study.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}